FPGA Acceleration for Bio Apps


By Salvatore Salamone

Mitrionics, which develops virtual processor and programming software for Field Programmable Gate Array (FPGA) supercomputing acceleration, announced the Mitrion-C Open Bio Project.

The project is an effort by Mitrionics to get its products better known within the life sciences community. At the same time, programs developed as part of the project will be available as open source tools that any researcher can use.

Currently, the company offers a virtual processor and C-like programming language for FPGAs. Essentially, the software permits researchers to tap the processing power of FPGAs by making C-like calls within an application. This contrasts to the traditional method of FPGA programming that relies on writing instructions in the less commonly known Hardware Description Language (HDL). (For a more detailed description about how the Mitrionics tools work, go here.)

With the Open Bio Project, Mitrionics will help make bioinformatics applications such as BLAST, Smith-Waterman, and Hidden Markov Models run faster using FPGAs. Applications developed through the project will run on the Mitrion Virtual Processor and will be contributed as open source applications for researchers in the bioinformatics community.

Mitrionics will develop some programs itself and it will rely on researchers who want to develop Mitrion-C bioinformatics applications on their own. To participate in the project, researchers can download the Mitrion Software Development Kit – Personal Edition (and a copy of a Mitrion-accelerated version of NCBI BLAST) at no charge from the Mitrionics website.

Currently, an accelerated BLAST program is being tested for use with the Mitrion Virtual Processor on the FPGA-based SGI RASC RC100 computation blade. The RASC blade works in SGI’s Altix line of servers. Mitrionics says it intends to support all FPGA-based computer systems from major vendors that are capable of running supercomputing applications.

Email Salvatore Salamone.

Subscribe to Bio-IT World  magazine.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.